Activities of José Inácio FARIA related to 2016/0261(COD)
Plenary speeches (1)
Information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances (A8-0359/2016 - Michał Boni) PT
Amendments (7)
Amendment 22 #
Proposal for a regulation
Recital 1
Recital 1
(1) New psychoactive substances can pose serious cross border threats to health, in particular due to their diversity and the speed with which they have been appearing, which makes necessary to enhance monitoring, early warning and combating of those threats.
Amendment 25 #
Proposal for a regulation
Recital 1 a (new)
Recital 1 a (new)
(1a) The term "psychoactive substances" refers to a broad category of unregulated psychoactive compounds or products containing them that are marketed as legal alternatives to well- known controlled drugs, usually sold via the internet or in "smart shops" or "head shops".
Amendment 26 #
Proposal for a regulation
Recital 1 b (new)
Recital 1 b (new)
(1b) It is possible that psychoactive substances are advertised with aggressive and sophisticated marketing strategies and are intentionally mislabelled, with declared ingredients differing from the actual composition. It is therefore necessary to take rapid action at Union level.
Amendment 27 #
Proposal for a regulation
Recital 2
Recital 2
(2) During the past years, Member States have notified an increasing number of new psychoactive substances via the mechanism for rapid exchange of information which was established by Joint Action 97/396/JHA adopted by the Council on the basis of Article K.3 of the Treaty on European Union concerning the information exchange, risk assessment and the control of new synthetic drugs13 and was further strengthened by Council Decision 2005/387/JHA14. According to the European Medicine Centre for Drugs and Drug addiction ("the Centre"), Member States notified 101 new psychoactive substances, which had not been reported previously, via that mechanism during the year 2014. __________________ 13 Council Joint Action 97/396/JHA of 16 June 1997 concerning the information exchange, risk assessment and control of new synthetic drugs (OJ L 167, 25.6.1997, p. 1). 14 Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk assessment and control of new psychoactive substances (OJ L 127, 20.5.2005, p. 32).
Amendment 30 #
Proposal for a regulation
Recital 2 a (new)
Recital 2 a (new)
(2a) This Regulation should take into account the fact that vulnerable groups, and especially young people, are particularly exposed to the public health, safety and social risks arising from new psychoactive substances.
Amendment 31 #
Proposal for a regulation
Recital 5
Recital 5
(5) Any Union action on new psychoactive substances should be based on scientific evidence. Given that in some cases new psychoactive substances could be so novel to the field that, at least initially, there would be very limited evidence from scientific research on public health risks, it is necessary to undertake rapid risk assessment procedures at Union level.
Amendment 34 #
Proposal for a regulation
Article 1 – paragraph 1 – point 3
Article 1 – paragraph 1 – point 3
Regulation (EC) No 1920/2006
Article 5a – paragraph 1
Article 5a – paragraph 1
Each Member State shall ensure that its Reitox National Focal Points and the Europol National Unit provide timely and without any undue delay to the Centre and Europol the available information on new psychoactive substances. The information shall be related to the detection and identification, use and patterns of use, potential and identified risks, manufacture, extraction, distribution, trafficking, cross- border global supply chains, commercial, as well as medical and scientific use of these substances.